New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes

about

BRCA mutations in the manifestation and treatment of ovarian cancer.

P2860

Q47134293-DD90A1CF-F845-4522-AAF7-9360ECF925F5

P2860

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes

Item

http://www.wikidata.org/entity/Q37519943

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New perspective on maintenance ...... tions in BRCA1 and BRCA2 genes

@en

New perspective on maintenance ...... ions in BRCA1 and BRCA2 genes.

@nl

type

Item

label

New perspective on maintenance ...... tions in BRCA1 and BRCA2 genes

@en

New perspective on maintenance ...... ions in BRCA1 and BRCA2 genes.

@nl

prefLabel

New perspective on maintenance ...... tions in BRCA1 and BRCA2 genes

@en

New perspective on maintenance ...... ions in BRCA1 and BRCA2 genes.

@nl

P1476

New perspective on maintenance ...... tions in BRCA1 and BRCA2 genes

@en

P2093

B Blaumeiser

http://www.w3.org/2001/XMLSchema#string

I Vergote

http://www.w3.org/2001/XMLSchema#string

J-F Baurain

http://www.w3.org/2001/XMLSchema#string

V Bours

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

Critical appraisal of bevacizumab in the treatment of ovarian cancer

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

Integrated genomic analyses of ovarian carcinoma

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Germline mutations in RAD51D confer susceptibility to ovarian cancer

Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.

Inherited Mutations in Women With Ovarian Carcinoma

Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.

P304

161-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28003870

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5172572

http://www.w3.org/2001/XMLSchema#string

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes

about

P2860

P2860

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932